Cancer-associated fibroblasts (CAFs) derived from MFAP2 promote CRC proliferation and metastasis while suppressing CD8&lt;sup&gt;+&lt;/sup&gt; T cell-mediated antitumor immunity. This evidence concerns the gene CD8A and colorectal carcinoma.